SCHEMBL18586548

SCHEMBL18586548

Cn1c2cc(-c3ccc(-c4ccc(N(c5ccccc5)c5cccc(-c6ccc(N(c7ccccc7)c7ccc(-c8ccc(-c9ccc%10c%11c%12ccccc%12ccc%11n(C)c%10c9)cc8)cc7)cc6)c5)cc4)cc3)ccc2c2cc3ccccc3cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.38
▸ RXRB P28702 1/20 0.38
▸ MAOB P27338 2/20 0.37
▸ CDK4 P11802 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ TSPO P30536 2/20 0.34
▸ PTGES O14684 1/20 0.33
▸ LIMK1 P53667 1/20 0.33
▸ FGFR1 P11362 1/20 0.32
▸ HTR1D P28221 1/20 0.32
▸ PABPC1 P11940 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18564891 0.95 MAOB (0.40) RXRARXRBMAOBCDK4CCND1
SCHEMBL18564892 0.95 MAOB (0.40) RXRARXRBMAOBCDK4CCND1
SCHEMBL18564929 0.94 MAOB (0.36) RXRARXRBMAOBCDK4CCND1
SCHEMBL18564776 0.91 MAOB (0.42) RXRARXRBMAOBCDK4CCND1
SCHEMBL18564867 0.91 MAOB (0.42) RXRARXRBMAOBCDK4CCND1
SCHEMBL18564828 0.91 MAOB (0.37) RXRARXRBMAOBCDK4CCND1
SCHEMBL18565009 0.90 RXRA (0.39) RXRARXRBMAOBTSPOPTGES
SCHEMBL18565011 0.90 RXRA (0.39) RXRARXRBMAOBTSPOPTGES
SCHEMBL18564894 0.90 RXRA (0.41) RXRARXRBMAOBTSPOLIMK1
SCHEMBL18564908 0.90 RXRA (0.41) RXRARXRBMAOBTSPOLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 RXRA 4249/4885RXRB 4487/4885MAOB 760/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 RXRA 4249/4885RXRB 4487/4885MAOB 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback